BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1977176)

  • 1. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse.
    Burke K; Chandler CJ; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1990 Aug; 36(4):729-33. PubMed ID: 1977176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
    Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
    Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant action of SCH 23390 in the striatum of the rat.
    al-Tajir G; Starr MS
    Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra.
    al-Tajir G; Starr MS
    Pharmacol Biochem Behav; 1991 May; 39(1):109-13. PubMed ID: 1924492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
    Alam AM; Starr MS
    Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse.
    Abbott B; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1991 Feb; 38(2):259-63. PubMed ID: 1676166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat.
    Alam AM; Starr MS
    Neuroscience; 1994 Jun; 60(4):1039-47. PubMed ID: 7936204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
    Levin ED; Ellison GD; See RE; South D; Young E
    Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anticonvulsant Effect of Hydroethanolic Leaf Extract of
    Obese E; Biney RP; Henneh IT; Adakudugu EA; Anokwah D; Agyemang LS; Woode E; Ameyaw EO
    Neural Plast; 2021; 2021():5566890. PubMed ID: 34257639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists.
    Day J; Fibiger HC
    Neuroscience; 1993 Jun; 54(3):643-8. PubMed ID: 8101359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
    Imperato A; Obinu MC; Gessa GL
    Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
    Barone P; Palma V; DeBartolomeis A; Tedeschi E; Muscettola G; Campanella G
    Eur J Pharmacol; 1991 Mar; 195(1):157-62. PubMed ID: 1829682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats.
    Zarrindast MR; Mamanpush SM; Rashidy-Pour A
    Gen Pharmacol; 1994 Jul; 25(4):803-8. PubMed ID: 7958745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yawning produced by dopamine agonists in rhesus monkeys.
    Code RA; Tang AH
    Eur J Pharmacol; 1991 Aug; 201(2-3):235-8. PubMed ID: 1686760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
    Messier C; Mrabet O; Destrade C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.